Form D — Theriva Biologics, Inc.
0001104659-25-101914 · filed 2025-10-24
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $13,109,494
- Total sold
- $13,109,494
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Theriva Biologics, Inc.
- CIK
- 894158
- Entity
- Corporation
- Jurisdiction
- NEVADA
- Year incorporated
- —
- Address
- 9605 MEDICAL CENTER DRIVE
ROCKVILLE, MD 20850 - Phone
- 301-417-4364
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Steven A. Shallcross · Executive OfficerRockville, MD Find on LinkedIn ↗
-
Jeffrey J. Kraws · DirectorRockville, MD Find on LinkedIn ↗
-
John Monahan · DirectorRockville, MD Find on LinkedIn ↗
-
Jeffrey A. Wolf · DirectorRockville, MD Find on LinkedIn ↗
View original on SEC EDGAR.